ECS Botanics Secures $9.9m cannabis supply agreement
- ECS Botanics (ECS) signs a $9.9 million supply agreement for medicinal cannabis products with German company Ilios Santé GmbH
- Under the contract, ECS will exclusively supply four medicinal cannabis strains to Ilios Sante, with the first supply anticipated once product registration is complete
- The products are anticipated to generate a minimum of $9.9 million in revenue for ECS over the deal’s three year term
- ECS told investors the German medicinal cannabis market is continuing to grow, with German legislators recently moving to legalise recreational use
- Shares in ECSBotanics last traded at 2.1 cents on January 3